Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis

Multiple Sclerosis

Volumn 14, Issue 9, 2008, Pages 1175-1180

  Tai, A K ^a   O'Reilly, E J ^b   Alroy, K A ^a   Simon, K C ^b   Munger, K L ^b   Huber, B T ^a   Ascherio, Alberto ^b,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Endogenous retroviruses; HERV K18; HLA; Multiple sclerosis; Plymorphisms

Indexed keywords

HLA DR ANTIGEN; SUPERANTIGEN; VIRUS ENVELOPE PROTEIN; IDDMK1,2 22 SUPERANTIGEN, HUMAN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ENDOGENOUS RETROVIRUS; EPSTEIN BARR VIRUS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE DETECTION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS INFECTION; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; VIROLOGY;

CASE-CONTROL STUDIES; ENDOGENOUS RETROVIRUSES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MEMBRANE PROTEINS; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SUPERANTIGENS;

EID: 59249089240     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508094641     Document Type: Article

References (24)

1. Rosati G. The prevalence of multiple sclerosis in the world: An update. Neurol Sci 2001; 22: 117-139.
2. Hunter SF Hafler DA. [editorial; comment] Ubiquitous pathogens: Links between infection and autoimmunity in MS. Neurology 2000; 55: 164-165.
3. Warner HB Carp RI. (letter) Multiple sclerosis and Epstein-Barr virus. Lancet 1981; 2: 1290.
4. Ascherio A Munch M. Epstein-Barr virus and multiple sclerosis. Epidemiology 2000; 11: 220-224.
5. Ascherio A Munger KL. Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol 2007; 61: 288- 299.
6. Thacker EL Mirzaei F Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: A meta-analysis. Ann Neurol 2006; 59: 499-503.
7. Levin LI Munger KL Rubertone MV. Temporal relationship between elevation of Epstein Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005; 293: 2496-2500.
8. Conrad B Weissmahr RN Böni J Arcari R Schüpbach J Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997; 90: 303-313.
9. Stauffer Y Marguerat S Meylan F. Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. Immunity 2001; 15: 591-601.
10. Hernán MA Olek MJ Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurology 1999; 53: 1711-1718.
11. The International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 851-862.
12. Ascherio A Zhang SM Hernan MA. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001; 344: 327-332.
13. de Bakker PIW McVean G Sabeti PC. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006; 38: 1166-1172.
14. Schaid DJ Jacobsen SJ. Biased tests of association: Comparisons of allele frequencies when departing from Hardy-Weinberg proportions. Am J Epidemiol 1999; 149: 706-711.
15. Hilton DA Love S Fletcher A Pringle JH. Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation. J Neurol Neurosurg Psychiatry 1994; 57: 975-976.
16. Sanders VJ Felisan S Waddell A Tourtellotte WW. Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neurovirol 1996; 2: 249-258.
17. Serafini B Rosicarelli B Franciotta D. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007; 204: 2899-2912.
18. Rand KH Houck H Denslow ND Heilman KM. Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis. J Neurol Sci 2000; 173: 32-39.
19. Lang HL Jacobsen H Ikemizu S. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 2002; 3: 940-943.
20. Lunemann JD Edwards N Muraro PA. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 2006; 129: 1493-1506.
21. Sutkowski N Palkama T Ciurli C Sekaly R-P Thorley-Lawson DA Huber BT. An Epstein-Barr virus-associated superantigen. J Exp Med 1996; 184: 971-980.
22. Klaman LD Thorley-Lawson DA. Characterization of the CD48 gene demonstrates a positive element that is specific to Epstein-Barr virus-immortalized B-cell lines and contains an essential NF-kappa B site. J Virol 1995; 69: 871-881.
23. Marguerat S Wang WY Todd JA Conrad B. Association of human endogenous retrovirus K-18 polymorphisms with type 1 diabetes. Diabetes 2004; 53: 852-854.
24. Tai AK Huber BT. Viral superantigens in mouse and man. In: Koth M; Fraser JD; (eds), Superantigens: Molecular basis for their role in human diseases; 2008. p. 59-76.